Lack of association between Helicobacter pylori and pediatric atopy: Evidence from a Latin American multicenter

Pamela Gil1, Claudia Rojo2, Manuel Lara Martín3

  • 1Division of Pediatrics, Department of Gastroenterology and Nutrition, School of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

Insights

Helicobacter pylori (H. pylori) infection showed no significant association with atopy in Latin American children. Further research is needed to understand the complex relationship between H. pylori and allergic conditions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infectious Diseases
  • Gastroenterology

Background:

  • The immune response to Helicobacter pylori (H. pylori) infection has led to postulations of a protective role against atopic conditions in children.
  • Understanding this potential inverse association is crucial for pediatric health.

Purpose of the Study:

  • To investigate the potential inverse association between H. pylori infection and the prevalence of asthma, rhinitis, and eczema in Latin American children.

Main Methods:

  • A cross-sectional study involving symptomatic patients referred for endoscopy in Cuba, Ecuador, and Chile.
  • Data collected via demographic information, International Study of Asthma and Allergies in Childhood III questionnaires, and endoscopy-based H. pylori testing.
  • Atopy defined as the presence of asthma, rhinitis, or eczema; multiple regression analyses performed.

Main Results:

  • Out of 251 enrolled children, 45% were infected with H. pylori and 56.2% had atopic conditions.
  • No significant association was found between H. pylori infection and the overall presence of atopy (59.6% vs. 53.3%, p > 0.05).
  • H. pylori infection was positively associated with age and rhinitis, and negatively associated with eosinophilic esophagitis.

Conclusions:

  • The study found similar frequencies of atopy in H. pylori-infected and uninfected children.
  • Larger cohort studies are required to definitively clarify the role of H. pylori in the development of atopic conditions.
Abstract

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
502
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.0K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
704
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K